News from the FDA/CDC
News from the FDA/CDC
CDC: Risk in U.S. from 2019-nCoV remains low
The genetic sequence for all five viruses detected in the United States to date has been uploaded the CDC website.
Conference Coverage
HHS: Coronavirus risk low in U.S., vaccine development underway
U.S. health providers should be on the lookout for any patient who has traveled to China recently.
News
FDA approves first treatment for advanced epithelioid sarcoma
Tazemetostat earns accelerated approval for the treatment of patients aged 16 years and older with metastatic or locally advanced epithelioid...
News from the FDA/CDC
Washington state patient is first U.S. case of novel coronavirus
News from the FDA/CDC
The measles comeback of 2019
Three-quarters of these cases in 2019 were linked to recent outbreaks in New York.
News from the FDA/CDC
FDA approves infliximab-axxq for numerous indications
This is the fourth biosimilar for this tumor necrosis factor inhibitor to receive FDA approval.
News from the FDA/CDC
FDA announces approval of fifth adalimumab biosimilar, Abrilada
Pfizer said that current plans are to launch the drug in the United States in 2023.
News from the FDA/CDC
FDA still concerned about biotin affecting troponin tests
The agency has issued an update to its 2017 safety communication.
Feature
President to nominate oncologist to lead FDA
President Trump has indicated his intent to nominate Stephen Hahn, MD, as FDA Commissioner.
News
FDA proposes new breast implant labeling with a boxed warning
Following a high-profile hearing in March 2019, and a textured breast implant recall in July, the FDA has proposed a boxed warning and other...
News from the FDA/CDC
New York declares end to 2018 measles outbreak
Reports of unrelated measles cases in the state continue.